ElsaLys Biotech completes venture financing

ElsaLys Biotech, Lyon, France Business: Antibodies, Cancer, Inflammation Date completed: 5/17/13 Type: Venture financing Raised: €2.1 million ($2.7 million) Investors: Transgene S.A.; Sofimac ...